肌缩侧面硬化症的诊断旅程:诊断标准和现实
Stanisław Maksymowicz1, Tomasz Siwek2,3
1Department of Psychology and Sociology of Health and Public Health, School of Public Health, Collegium Medicum of the University of Warmia and Mazury, Warszawska 30 Street, 10-082, Olsztyn, Poland. stanislaw.maksymowicz@uwm.edu.pl.
概括
诊断肌缩侧面硬化症 (ALS) 是具有挑战性的,导致患者长期的"诊断旅程". 延误和错误诊断显著影响生活质量和疾病进展.
科学领域:
- 神经学 神经学
- 罕见疾病 罕见疾病
- 患者体验 患者体验
背景情况:
- 诊断罕见疾病,如肌缩性侧面硬化症 (ALS) 给医生和患者带来了重大挑战.
- 对于ALS的诊断过程往往偏离了既定的标准,导致了长期的诊断旅程.
- 这项研究调查了诊断旅程的进展及其对ALS患者的影响.
研究的目的:
- 为了阐明在肌缩侧面硬化症的诊断旅程的典型进展.
- 了解诊断奥德赛对被诊断为ALS的患者的影响.
- 确定罕见神经系统疾病的诊断途径需要改进的领域.
主要方法:
- 对被诊断患有ALS的24名患者进行了深入访谈和问卷调查.
- 参与者从神经病学诊所的环境中招募.
- 这项研究包括9名女性和15名男性,年龄在30至69岁之间.
主要成果:
- 从症状发作到诊断的中位时间是近12个月,平均约20个月.
- 大多数患者 (超过80%) 接受了不正确的初始诊断.
- 在24名患者中,只有5名患者在症状出现6个月内被诊断出来.
结论:
- 在ALS中延迟诊断和误诊可以加速疾病的进展,并对患者的生活质量产生负面影响.
- 从医学教育开始,提高医务人员的临床和沟通技能至关重要.
- 应该更新ALS的诊断标准,以更好地反映诊断中的常见挑战.
更多相关视频
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
Diagnostic and Statistical Manual of Mental Disorders (DSM)
95
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
95
Formulating and Validating Nursing Diagnosis II
2.8K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
2.8K
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521


